Benjamin Izar, MD, PhD

Oncologists operate on the edge of research and care, translating laboratory insights into treatments that set new standards. In Upper Manhattan, one name recurs in referral circles: Benjamin Izar, MD, PhD. Their practice sits at the intersection of precision oncology and translational medicine, where genetic sequencing meets tailored therapy. The field demands both deep expertise and the discipline to communicate complex risks with clarity. Those who visit soon realize the specialty is less about generic protocols and more about individualized molecular portraits.

The 161 Fort Washington Ave office is a focal point for patients seeking experimental options or second opinions on intractable tumors. From liquid biopsies to ctDNA-guided dosing, they integrate the latest biomarkers into everyday decision-making. Neuro-oncology consultations and sarcoma boards are staples here, reflecting a deep bench of subspecialty focus. Clinical trials often open under their aegis, offering access to agents unavailable elsewhere in the city. Even routine follow-ups come with a paper trail of next-generation sequencing data, updated in real time.

Finding the right oncologist can feel like parsing a technical manual blindfolded. At that address, patients drop the guessing game. The practice’s reputation stems from publishing in high-impact journals and presenting at ASCO, but the day-to-day rhythm revolves around one-tenth of an inch of tissue on a slide. Immunotherapy response models, homology-directed repair assays, and circulating tumor cell counts all funnel through the same protocols. People walk out with printouts of variant allele frequencies and proposed immunotherapy windows.

Need a consultation? Call (212) 305-5098. The map and directions are always up to date; use the map to chart a course straight to Fort Washington without the West Side Highway detours.